skip to Main Content
MSJ NEWS see latest news

Connecticut Innovations Increases Early-Stage Investments to $9.4 Million in Q3 of 2021 Fiscal Year

  • Connecticut Innovations announces $9.4 million in investments in early-stage Connecticut companies for the third quarter of its fiscal year
  • Investments are concentrated in bioscience, health care information technology, and IT companies
  • Funding helps leverage $124 million in outside capital

Summary by Dirk Langeveld

Connecticut Innovations announced that it invested $9.4 million in early-stage companies in Connecticut in the third quarter of its fiscal year, which ended March 31. The investment marks an increase from the second quarter, which saw $7.2 million in investments.

Connecticut Innovations said the investments:

  • Involved 36 transactions
  • Allocated $4.3 million to bioscience and health care information technology companies, as well as $1.8 million to IT companies
  • Leveraged $124 million in outside capital
  • Provided the largest sums to the Mystic-based agricultural science company Enko Chem, the New Haven-based health software company Inbox Health, the lung cancer treatment company Lumeda of Rocky Hill, and the autonomous maritime surveillance company ThayerMahan of Groton

Spread the Word

More To Explore

Expert Summaries

Know Your Competitors

By Denis Jakuc 

There are tons of benefits to knowing who your competitors are—what they’re offering, their strengths and weaknesses. That knowledge can help you make your products and services stand out,

Latest News

Join with Free InnovatorsLINK Account

Start accessing all the free member benefits and valuable content on the InnovatorsLINK platform. Create a BizLINK listing to boost brand exposure, receive the weekly Main Street Journal newsletter, engage in forums, get full access to free content, and more.